GHK-Cu: can copper peptide creams and shots help your skin age well?

GHK-Cu is a small copper-binding peptide found naturally in your blood, saliva and urine, and its levels fall with age. In skin care it's used as a cosmetic ingredient, and small studies suggest some skin and wound benefits. Injections are different: human data are limited, and FDA has flagged a risk of immune reactions. A physician can help with what's proven to keep skin and body healthy.

Reviewed by Darshan Patel, MD, Obesity medicine physician, on 2026-11-12. Next review 2026-12-12.

Book my consultation Video consultations with an Aayu Well physician. Most major insurance accepted, plus convenient cash pay options.

Why people are curious about GHK-Cu

GHK-Cu, often called copper peptide, turns up in serums and creams for firmer, smoother skin, and people also ask about it as an injection for skin and healing. It's part of you already: GHK is found in your blood, saliva and urine, and the amount falls as you age. Researchers think it works by carrying copper, which may help wounds heal and skin repair itself.

Wanting healthy skin as you age is a great goal. The real question is whether GHK-Cu is the best way to get there.

What the research shows so far

Evidence grade C on the skin, D for injections. There are a few small human studies of skin and wound products, and almost none of injections. How we grade evidence.

• On the skin: in a randomized study of 13 people healing from laser skin resurfacing, a GHK-Cu skin care routine didn't speed the fading of redness or change wrinkle scores, though people who used it rated their skin better. A 2015 review reports that, in cosmetic products, GHK-Cu tightened loose skin and improved elasticity and firmness.
• For wounds: in a randomized, placebo-controlled trial in people with diabetic foot ulcers, a GHK-Cu gel applied after dead tissue was removed helped ulcers close more than a plain gel, with fewer infections. That was a wound-care gel, not a beauty product.
• As an injection: mostly lab and animal studies, such as a rat study of knee ligament surgery. FDA says there are limited data in humans.
• Still open: whether creams change skin in larger trials, and whether injections help anything or are safe. A 2026 review of peptides sold directly to patients found rigorous human safety data scarce.

Your goal, with stronger evidence behind it

Most people who ask about GHK-Cu want healthy-looking skin and to age well. Here's what has been tested in people.

• Protect your skin every day. In a randomized trial of 903 adults followed for about four and a half years, people who used sunscreen daily showed no detectable increase in skin aging, and their skin aged 24% less than those who used it now and then.
• Feel better in your body. For people living with obesity, GLP-1 medicines such as semaglutide and tirzepatide have been tested in large trials with thousands of adults. They led to far more weight loss than placebo and improved heart and metabolic health numbers.
• Keep your muscle while you lose fat. In a 6-month trial of 160 older adults losing weight, those who added strength training lost less muscle than those who only did aerobic exercise. At Aayu Well, a registered dietitian helps you build meals that support your muscle as the weight comes off.

Aayu Elevate™ puts this together: video visits with an obesity medicine physician, a registered dietitian, and medicine when it's right for you. Most major insurance accepted, plus convenient cash pay options. Book my consultation

Is GHK-Cu legal now?

It depends on the form. Skin care with GHK-Cu is sold as a cosmetic, and cosmetics don't need FDA approval before they're sold. Injectable GHK-Cu isn't part of the October 2026 HHS policy, which covers six other peptides and doesn't reach peptides outside its list. FDA lists it among compounding nominations that were withdrawn after it sat in FDA's category for ingredients with significant safety risks. We couldn't confirm from FDA where compounded GHK-Cu creams stand. See which peptides can be compounded.

Good to know before you try it

• Compounded GHK-Cu is not FDA-approved, and FDA doesn't check compounded drugs for safety, effectiveness or quality before they're sold.
• FDA warns that compounded GHK-Cu injections may set off an immune reaction, because the peptide can clump and carry impurities.
• Cosmetics don't go through FDA approval. Under FDA rules, a product meant to change how your body works is a drug, not a cosmetic.
• Products labeled research use only aren't made or tested for people. Here's why that label matters.
• Tell every physician who treats you what you use, including injections, especially if you're on a GLP-1.

Where Aayu Well stands

We don't prescribe GHK-Cu right now. We're following the research and the pharmacy rules closely, and we review this page every month.

What we can help with today is usually what sits behind the question: weight, metabolic health, energy, sleep and mood. Bring your peptide questions to your first visit. Your physician will give you a straight answer and a plan built around you.

Questions people ask

Can I talk to an Aayu Well physician about peptides?

Yes, and we'd encourage it. Bring your questions to your visit. We don't prescribe GHK-Cu right now, but your physician will go over the evidence with you, review everything you take, and build a plan for the goal behind the question, whether that's healthy aging, weight, energy or sleep.

Is GHK-Cu legal?

It depends on the form. Skin care with GHK-Cu is sold as a cosmetic, and cosmetics don't need FDA approval before sale. As of November 12, 2026, injectable GHK-Cu isn't covered by the October 2026 HHS peptide policy, and FDA lists it among compounding nominations that were withdrawn after FDA flagged safety risks.

Do copper peptide creams work?

The evidence is small. In a randomized study of 13 people healing from laser skin treatment, a GHK-Cu skin care routine didn't change redness or wrinkle scores, though people rated their skin better. Daily sunscreen has much stronger evidence for keeping skin younger-looking.

Are GHK-Cu injections safe?

There isn't enough research in people to say. FDA warns that compounded GHK-Cu injections may set off an immune reaction because the peptide can clump and carry impurities, and that human data are limited.

Can I use it with a GLP-1 like Wegovy or Zepbound?

We haven't found studies of the two together, so it's worth a conversation first. Tell the physician who prescribes your GLP-1 about any peptide you use, including injections.

Sources

1. FDA: Certain bulk drug substances for use in compounding that may present significant safety risks (content current as of April 22, 2026)
2. Federal Register notice FR Doc. 2026-22192, Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances, 91 FR 68526 (October 30, 2026)
3. Holland & Knight: HHS Issues Interim Enforcement Discretion Policy for Compounding of 6 Peptides (November 4, 2026)
4. 21 CFR 216.23: Bulk drug substances that can be used to compound drug products in accordance with section 503A
5. FDA: FDA authority over cosmetics, how cosmetics are not FDA-approved but are FDA-regulated
6. FDA: Compounding and the FDA, questions and answers
7. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108.
8. Miller TR, et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-259.
9. Mulder GD, et al. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper. Wound Repair Regen. 1994;2(4):259-269.
10. Fu SC, et al. Tripeptide-copper complex GHK-Cu (II) transiently improved healing outcome in a rat model of ACL reconstruction. J Orthop Res. 2015;33(7):1024-1033.
11. Mendias CL, Awan TM. Safety and efficacy of approved and unapproved peptide therapies for musculoskeletal injuries and athletic performance. Sports Med. 2026;56(8):1921-1935.
12. Hughes MCB, et al. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med. 2013;158(11):781-790.
13. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002.
14. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216.
15. Villareal DT, et al. Aerobic or resistance exercise, or both, in dieting obese older adults. N Engl J Med. 2017;376(20):1943-1955.